Labcorp gets CDSCO nod to conduct a study on anticancer drug Dr. Divya Colin20 March 2022 11:15 AM ISTNew Delhi: In a significant development, Labcorp, a leading global life sciences company, has received approval from the Central Drugs Standard...
IQVIA gets CDSCO panel nod to conduct study of ASLAN004 for atopic dermatitis Dr. Divya Colin20 March 2022 10:15 AM ISTNew Delhi: Drug maker IQVIA has got approval from the Central Drugs Standard Control Organization (CDSCO) to conduct a Phase IIb clinical trial of...
GSK gets CDSCO panel okay to conduct study on antineoplastic drug Belantamab Mafadotin Dr. Divya Colin18 March 2022 2:05 PM ISTNew Delhi: In a significant development, GSK Pharmaceuticals ( India) has got approval from the Subject Expert Committee (SEC) of the Central Drug...
Natco Pharma gets CDSCO nod to manufacture, market anti neoplastic drug Idelalisib Dr. Divya Colin16 March 2022 6:52 PM ISTNew Delhi: In a significant development, Natco Pharma has got the go-head from the Subject Expert Committee (SEC) of the Central Drug Standard Control...
Bristol Myers Squibb Nivolumab marketing approval to be revoked for hepatocellular carcinoma: CDSCO panel Dr. Divya Colin14 March 2022 6:30 PM ISTNew Delhi: In a major setback for Bristol Myers Squibb, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO)...
Dr. Roddy's gets CDSCO panel nod to manufacture & market Treprostinil solution for Infusion Dr. Divya Colin12 March 2022 1:51 PM ISTNew Delhi: Granting a local clinical trial waiver, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has...
Sanofi gets CDSCO panel okay to market Quadrivalent Inactivated Influenza vaccine Dr. Divya Colin12 March 2022 1:47 PM ISTNew Delhi: Pharma major, Sanofi has got the go-head from the Subject Expert Committee (SEC) of the Central Drug Standard Control Organization (CDSCO)...
Setback: GSK proposal to market Meningococcal group B Vaccine rejected by CDSCO panel Dr. Divya Colin11 March 2022 5:08 PM ISTNew Delhi: In the major setback to GSK, citing that the firm has not submitted any safety and immunogenicity data in Indian population, the Subject...
Roche India Atezolizumab marketing approval to be revoked for two indications: CDSCO panel Susmita Roy10 March 2022 6:50 PM ISTNew Delhi: In a major setback to Roche Products (India), the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO)...
Sanofi gets CDCSO panel okay to study Antiasthmatic drug Dupilumab Dr. Divya Colin9 March 2022 6:58 PM ISTNew Delhi: Pharmaceutical major, Sanofi has got the go-head from the Subject Expert Committee (SEC) of the Central Drug Standard Control Organization...
GSK gets CDSCO panel nod to market Mepolizumab for two rare disease indications Dr. Divya Colin8 March 2022 4:11 PM ISTNew Delhi: Pharmaceutical major, GSK has got a go-head from the Subject Expert Committee (SEC) of the Central Drug Standard Control Organization...
CDSCO SEC okays Covovax for 12-17 year-olds Medical Dialogues Bureau6 March 2022 5:06 PM ISTNew Delhi: The Subject Expert Committee (SEC) has recommended granting emergency use authorisation (EUA) to Serum India of India's COVID-19 vaccine...
